Pyridoxal 5'-phosphate

ID189
NamePyridoxal 5'-phosphate
Synonyms[Vitamin B6] / Pyridoxal phosphate; PLP
StructureThumb
DescriptionActive form of vitamin B6.
GroupPyridines
Sub-groupHydroxypyridines
Exposure sourceDiet
UseVitamins
CAS number54-47-7
PubChem ID1051
ChEBI ID18405
FooDB IDFDB021820
HMDB IDHMDB01491

Biomarker measurements

Biomarker concentration values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
12380MalesParticipants in a dietary validation studyJapanJPJPHC StudyPlasma, fastingHPLCPyridoxal 5'-phosphate90204.7192.8nmol/L204.7 nmol/LCrudeKobayashi 2011
15210FFQ 1 - Quintile 1 (Vitamin intake: unspecified)Controls in a case-control study on B vitamins and prostate cancerSwedenSEVIP cohort (Vasterbotten Intervention Project)Plasma, fastingLC-MS/MSPyridoxal 5'-phosphate10632.3pmol/L0.0 nmol/LCrudeJohansson 2010
15220FFQ 1 - Quintile 2 (Vitamin intake: unspecified)Controls in a case-control study on B vitamins and prostate cancerSwedenSEVIP cohort (Vasterbotten Intervention Project)Plasma, fastingLC-MS/MSPyridoxal 5'-phosphate10631.1pmol/L0.0 nmol/LCrudeJohansson 2010
15230FFQ 1 - Quintile 3 (Vitamin intake: unspecified)Controls in a case-control study on B vitamins and prostate cancerSwedenSEVIP cohort (Vasterbotten Intervention Project)Plasma, fastingLC-MS/MSPyridoxal 5'-phosphate10637.2pmol/L0.0 nmol/LCrudeJohansson 2010
15240FFQ 1 - Quintile 4 (Vitamin intake: unspecified)Controls in a case-control study on B vitamins and prostate cancerSwedenSEVIP cohort (Vasterbotten Intervention Project)Plasma, fastingLC-MS/MSPyridoxal 5'-phosphate10638.2pmol/L0.0 nmol/LCrudeJohansson 2010
15250FFQ 1 - Quintile 5 (Vitamin intake: unspecified)Controls in a case-control study on B vitamins and prostate cancerSwedenSEVIP cohort (Vasterbotten Intervention Project)Plasma, fastingLC-MS/MSPyridoxal 5'-phosphate10648.2pmol/L0.0 nmol/LCrudeJohansson 2010
15310FFQ 2 - Quintile 1 (Vitamin intake: unspecified)Controls in a case-control study on B vitamins and prostate cancerSwedenSEVIP cohort (Vasterbotten Intervention Project)Plasma, fastingLC-MSPyridoxal 5'-phosphate6831.3pmol/L0.0 nmol/LCrudeJohansson 2010
15320FFQ 2 - Quintile 2 (Vitamin intake: unspecified)Controls in a case-control study on B vitamins and prostate cancerSwedenSEVIP cohort (Vasterbotten Intervention Project)Plasma, fastingLC-MSPyridoxal 5'-phosphate6833.9pmol/L0.0 nmol/LCrudeJohansson 2010
15330FFQ 2 - Quintile 3 (Vitamin intake: unspecified)Controls in a case-control study on B vitamins and prostate cancerSwedenSEVIP cohort (Vasterbotten Intervention Project)Plasma, fastingLC-MSPyridoxal 5'-phosphate6839.3pmol/L0.0 nmol/LCrudeJohansson 2010
15340FFQ 2 - Quintile 4 (Vitamin intake: unspecified)Controls in a case-control study on B vitamins and prostate cancerSwedenSEVIP cohort (Vasterbotten Intervention Project)Plasma, fastingLC-MSPyridoxal 5'-phosphate6835.0pmol/L0.0 nmol/LCrudeJohansson 2010
15350FFQ 2 - Quintile 5 (Vitamin intake: unspecified)Controls in a case-control study on B vitamins and prostate cancerSwedenSEVIP cohort (Vasterbotten Intervention Project)Plasma, fastingLC-MSPyridoxal 5'-phosphate6843.1pmol/L0.0 nmol/LCrudeJohansson 2010
32840MalesHigh school studentsTaiwanTWPlasma, fastingHPLCPyridoxal 5'-phosphate6558.117.6nmol/L58.1 nmol/LCrudeChang 2007
32860FemalesHigh school studentsTaiwanTWPlasma, fastingHPLCPyridoxal 5'-phosphate6257.219.3nmol/L57.2 nmol/LCrudeChang 2007

Intake values

No data available

Correlation values

Reproducibility values

IDMst. IDSubject groupPopulationCountryCountry codeCohortTime definitionBiological specimenExperimental methodBiomarkerBiomarker detailArithmetic meanGeometric meanMedianUnitAdjusted onReproducibility sizeICCICC 95% CI lowerICC 95% CI upperCV% WSCV% BSVAR WSVAR BSPublication
411764All [by diagnosis]Elderly subjects with and without mild cognitive impairmentUnited StatesUSbaseline; 1 monthPlasma, fastingRadioimmunoassayPyridoxal 5'-phosphatemissing unit380.8Bowman 2011
711742No cognitive impairmentElderly subjects with and without mild cognitive impairmentUnited StatesUSbaseline; 1 monthPlasma, fastingRadioimmunoassayPyridoxal 5'-phosphatemissing unit190.77Bowman 2011
931720Mild cognitive impairmentElderly subjects with and without mild cognitive impairmentUnited StatesUSbaseline; 1 monthPlasma, fastingRadioimmunoassayPyridoxal 5'-phosphatemissing unit190.94Bowman 2011
61219083AllDutch participants of the EPIC-StudyNetherlandsNLMORGEN-EPIC projectbaseline; 3 yearsSerum, non-fastingHPLCPyridoxal 5'-phosphatenmol/L600.410.210.57Leenders 2013
66919126MalesCollege students consuming a semi-purified diet with water-soluble vitaminsJapanJPbaseline; 2 day; 4 days; 7 daysWhole blood, fastingHPLCPyridoxal 5'-phosphatemmol/L1016.043.7Shibata 2009
68719144FemalesCollege students consuming a semi-purified diet with water-soluble vitaminsJapanJPbaseline; 2 day; 7 daysWhole blood, fastingHPLCPyridoxal 5'-phosphatemmol/L1011.933.8Shibata 2009